Menu UNITED KINGDOM UK Our Impact Section 172 Statements Section 172 Statements Section 172 of the Companies Act 2006 requires the directors of the company to act in the way that they consider, in good faith, would most likely promote the success of the company for the benefit of its owners and stakeholders Our statements, available below, highlight a range of issues considered by the Board and examples of how the Board considers the interests of our stakeholders, including the impact of the Company’s activities on the community, the environment, and our reputation. 2020 statements TEVA Holding Companies s172 Statement 2020 TEVA Norton Healthcare Ltd s172 Statement 2020 TEVA Orvet UK s172 Statement 2020 TEVA UK s172 Statement 2020 Modern Slavery Act Statements As a UK based company we publish Modern Slavery Act Statements Learn more Our Impact We are dedicated to promoting health and increasing access to treatment for patients Discover more Date of preparation: October 2021 Reference: COB-GB-NP-00041 Contacts Contact us Reporting side effects Teva worldwide Clinical trials Website Information Terms and conditions Privacy policy Pharmacovigilance privacy policy Accessibility About Latest news COVID 19 Modern Slavery Act Follow Teva Facebook Twitter Linkedin Linkedin Registered in England No. 302461. Registered office: Teva UK Limited, Whistler Drive, Castleford, WF10 5HX We would like to collect some of your data to enhance your browsing experience, analyse, and measure your engagement with our content. By clicking [Accept] you consent to this and to sharing this data with our partners, including to serve you more relevant ads on other websites. If you continue without accepting, this cannot take place or will be less accurate. You can change your mind at any time. To find out more about your rights, our practices, the data we collect and our partners, click here. Reject All Accept Your Choices